Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Revista de la Facultad de Medicina
Print version ISSN 0120-0011
Abstract
ESCOBAR, Hellmann Adrián et al. Pharmacological treatment of Kawasaki disease. rev.fac.med. [online]. 2019, vol.67, n.1, pp.103-108. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v67n1.64144.
Introduction:
Kawasaki disease is a systemic vasculitis of unknown origin and its main complication is the formation of coronary aneurysms.
Objective:
To conduct an updated review of the literature on the pharmacological treatment of Kawasaki disease.
Materials and methods:
A structured literature search was conducted in the ProQuest, EBSCO, ScienceDirect, PubMed, LILACS, Embase, Trip Database, SciELO and Cochrane Library databases with the terms "Kawasaki disease AND therapeutics", "Kawasaki disease AND treatment" and "Mucocutaneous Lymph Node Syndrome AND therapeutics", in English and their equivalents in Spanish.
Results:
51 articles were found with information relevant for this review.
Conclusions:
Early diagnosis and treatment of Kawasaki disease is essential to prevent coronary complications. Treatment includes combined therapy with acetylsalicylic acid plus immunoglobulin G, which reduces the incidence of coronary aneurysms. On the other hand, corticosteroid therapies and other immunosuppressive drugs are alternatives used to treat immunoglobulin-resistant Kawasaki disease.
Keywords : Kawasaki Disease; Drug Therapy; Therapeutic; Mucocutaneous Lymph Node Syndrome (MeSH).
